Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Grosso, Giuseppe ^a   Pajak, Andrzej ^b   Marventano, Stefano ^a   Castellano, Sabrina ^a   Galvano, Fabio ^a   Bucolo, Claudio ^a   Drago, Filippo ^a   Caraci, Filippo ^a,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLPHENIDATE; ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; CITALOPRAM; CLOZAPINE; COCONUT OIL; CORN OIL; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID PLUS EICOSAPENTAENOIC ACID; ETHYLEICOSAPENTAENOIC ACID; ETHYLEICOSAPENTAENOIC ACID PLUS FLUOXETINE; FLUOXETINE; ICOSAPENTAENOIC ACID; LEVODOPA; LINOLENIC ACID; LIQUID PARAFFIN; LORAZEPAM; MINERAL OIL; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; PRAMIPEXOLE; RAPESEED OIL; SAFFLOWER OIL; SOYBEAN OIL; SUNFLOWER OIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VITAMIN B GROUP;

ADJUVANT THERAPY; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; MONOTHERAPY; PARKINSON DISEASE; PERINATAL DEPRESSION; PSYCHOTHERAPY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; TREATMENT DURATION; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; MEDLINE; METABOLISM; PATHOLOGY; PREGNANCY;

DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MEDLINE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84900529192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096905     Document Type: Article

References (128)

1. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B (2012) Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 5: 808-818.
2. Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, et al. (2014) Omega-3 Fatty Acids and Depression: Scientific evidence and Biological Mechanisms. Oxid Med Cell Longev 2014: 313570.
3. Machado-Vieira R, Mallinger AG (2012) Abnormal function of monoamine oxidase-A in comorbid major depressive disorder and cardiovascular disease: pathophysiological and therapeutic implications (review). Mol Med Rep 6: 915-922.
4. Do DP, Dowd JB, Ranjit N, House JS, Kaplan GA (2010) Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med 72: 613-619.
5. Severus WE, Littman AB, Stoll AL (2001) Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 9: 280-293. (Pubitemid 33010370)
6. Bourre JM (2004) Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 8: 163-174.
7. Hennebelle M, Balasse L, Latour A, Champeil-Potokar G, Denis S, et al. (2012) Influence of omega-3 fatty acid status on the way rats adapt to chronic restraint stress. PLoS One 7: e42142.
8. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, et al. (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24: 27-53.
9. Rees AM, Austin MP, Owen C, Parker G (2009) Omega-3 deficiency associated with perinatal depression: case control study. Psychiatry Res 166: 254-259.
10. Schins A, Crijns HJ, Brummer RJ, Wichers M, Lousberg R, et al. (2007) Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatr Scand 115: 35-40. (Pubitemid 44973549)
11. Frasure-Smith N, Lesperance F, Julien P (2004) Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55: 891-896. (Pubitemid 38526301)
12. Parker GB, Heruc GA, Hilton TM, Olley A, Brotchie H, et al. (2006) Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res 141: 279-286.
13. Assies J, Pouwer F, Lok A, Mocking RJ, Bockting CL, et al. (2010) Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 5: e10635.
14. Bloch MH, Hannestad J (2012) Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 17: 1272-1282.
15. Martins JG, Bentsen H, Puri BK (2012) Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry 17: 1144-1149; discussion 1163-1147.
16. Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, et al. (2012) Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry 17: 1161-1163; author reply 1163-1167.
17. Association AP (2000) Diagnostic and Statistical Manual of Mental Disorders; 4th, editor. Washington, DC. 317-345 p.
18. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296.
19. Beck AT (1978) Depression Inventory. Center for Cognitive Therapy; Philadelphia.
20. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389. (Pubitemid 9136500)
21. Picardi A (2009) Rating scales in bipolar disorder. Curr Opin Psychiatry 22: 42-49.
22. Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381: 1672-1682.
23. Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, et al. (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65: 805-815. (Pubitemid 351957706)
24. Otto SJ, de Groot RH, Hornstra G (2003) Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69: 237-243. (Pubitemid 37463804)
25. Bylund DB, Reed AL (2007) Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem Int 51: 246-253. (Pubitemid 47374323)
26. Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, et al. (2012) Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev 11: CD008324.
27. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, et al. (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84: 1308-1316. (Pubitemid 44912811)
28. Appleton KM, Rogers PJ, Ness AR (2010) Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 91: 757-770.
29. Sublette ME, Ellis SP, Geant AL, Mann JJ (2011) Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 72: 1577-1584.
30. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12. (Pubitemid 26120810)
31. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, et al. (2009) Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 63: 1037-1040.
32. Ness AR, Gallacher JE, Bennett PD, Gunnell DJ, Rogers PJ, et al. (2003) Advice to eat fish and mood: a randomised controlled trial in men with angina. Nutr Neurosci 6: 63-65. (Pubitemid 36157533)
33. Beezhold BL, Johnston CS (2012) Restriction of meat, fish, and poultry in omnivores improves mood: a pilot randomized controlled trial. Nutr J 11: 9.
34. Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, et al. (2006) Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins Leukot Essent Fatty Acids 75: 315-321. (Pubitemid 44442915)
35. Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85: 1392-1400. (Pubitemid 46740484)
36. Mattes E, McCarthy S, Gong G, van Eekelen JA, Dunstan J, et al. (2009) Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav Immun 23: 380-388.
37. Andreeva VA, Galan P, Torres M, Julia C, Hercberg S, et al. (2012) Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial. Am J Clin Nutr 96: 208-214.
38. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, et al. (2010) Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 304: 1675-1683.
39. Behan PO, Behan WM, Horrobin D (1990) Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 82: 209-216. (Pubitemid 20328916)
40. Sohrabi N, Kashanian M, Ghafoori SS, Malakouti SK (2013) Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: "a pilot trial". Complement Ther Med 21: 141-146.
41. Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, et al. (2003) Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev 8: 171-179. (Pubitemid 36676184)
42. Puolakka J, Makarainen L, Viinikka L, Ylikorkala O (1985) Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 30: 149-153. (Pubitemid 15090370)
43. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
44. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
45. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL (2004) Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr 80: 1167-1174. (Pubitemid 41350675)
46. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, et al. (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31: 1393-1396. (Pubitemid 47304478)
47. da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, et al. (2008) Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111: 351-359.
48. Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, et al. (2008) Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry 42: 192-198. (Pubitemid 351234188)
49. Hallahan B, Hibbeln JR, Davis JM, Garland MR (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 190: 118-122.
50. Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, et al. (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 23: 161-169. (Pubitemid 351308496)
51. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, et al. (2009) Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 33: 49-52.
52. Fontani G, Corradeschi F, Felici A, Alfatti F, Bugarini R, et al. (2005) Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with Omega-3 polyunsaturated fatty acids. Eur J Clin Invest 35: 499-507. (Pubitemid 41153204)
53. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, et al. (2011) Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life. J Nutr Health Aging 15: 37-44.
54. Peet M, Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59: 913-919.
55. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59: 7-10. (Pubitemid 41797469)
56. Warren G, McKendrick M, Peet M (1999) The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 99: 112-116. (Pubitemid 29064317)
57. Fux M, Benjamin J, Nemets B (2004) A placebo-controlled cross-over trial of adjunctive EPA in OCD. J Psychiatr Res 38: 323-325. (Pubitemid 38299170)
58. Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, et al. (2004) Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry 161: 1922-1924. (Pubitemid 39314692)
59. Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, et al. (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60: 1020-1022. (Pubitemid 44739928)
60. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, et al. (2012) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 107: 1682-1693.
61. Gracious BL, Chirieac MC, Costescu S, Finucane TL, Youngstrom EA, et al. (2010) Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord 12: 142-154.
62. Bot M, Pouwer F, Assies J, Jansen EH, Beekman AT, et al. (2011) Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study. Neuropsychobiology 63: 219-223.
63. Chiu CC, Huang SY, Chen CC, Su KP (2005) Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. J Clin Psychiatry 66: 1613-1614. (Pubitemid 43068708)
64. Peet M, Horrobin DF (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 36: 7-18. (Pubitemid 34037843)
65. Frangou S, Lewis M, McCrone P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188: 46-50. (Pubitemid 43021926)
66. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, et al. (2012) Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 26: 988-995.
67. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, et al. (2008) Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 88: 706-713.
68. Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ, et al. (2013) The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. Am J Obstet Gynecol 208: 313 e311-319.
69. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, Shariati-Bafghi SE (2013) Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 23: 636-644.
70. Lucas M, Asselin G, Merette C, Poulin MJ, Dodin S (2009) Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 89: 641-651.
71. Sterne JA, Egger M, Smith GD (2001) Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 323: 101-105. (Pubitemid 32681979)
72. deeks JJ, Altman DG, Bradbrun MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. London. 285-312 p.
73. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a metaanalysis. Stat Med 21: 1539-1558.
74. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
75. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, et al. (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56: 407-412. (Pubitemid 29215428)
76. Nemets B, Stahl Z, Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159: 477-479. (Pubitemid 34184747)
77. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, et al. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160: 996-998. (Pubitemid 41079588)
78. Su KP, Huang SY, Chiu CC, Shen WW (2003) Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13: 267-271. (Pubitemid 36904053)
79. Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72: 211-218. (Pubitemid 40139086)
80. Frangou S, Lewis M, Wollard J, Simmons A (2007) Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol 21: 435-439. (Pubitemid 47077299)
81. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, et al. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32: 1538-1544.
82. Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, et al. (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69: 644-651. (Pubitemid 351792341)
83. Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, et al. (2009) A double-blind, randomized controlled trial of ethyl- eicosapentaenoate for major depressive disorder. J Clin Psychiatry 70: 1636-1644.
84. Gertsik L, Poland RE, Bresee C, Rapaport MH (2012) Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol 32: 61-64.
85. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, et al. (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188: 1348-1353. (Pubitemid 36589134)
86. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99: 421-431.
87. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, et al. (2009) Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 302: 1651-1657.
88. Antypa N, Van der Does AJ, Smelt AH, Rogers RD (2009) Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol 23: 831-840.
89. Antypa N, Smelt AH, Strengholt A, Van der Does AJ (2012) Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals. J Psychopharmacol 26: 738-743.
90. Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158: 2071-2074. (Pubitemid 33104119)
91. Zanarini MC, Frankenburg FR (2003) omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 160: 167-169. (Pubitemid 36042442)
92. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, et al. (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67: 146-154.
93. Rees AM, Austin MP, Parker GB (2008) Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42: 199-205.
94. Bot M, Pouwer F, Assies J, Jansen EH, Diamant M, et al. (2010) Eicosapentaenoic acid as an add-on to antidepressant medication for comorbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study. J Affect Disord 126: 282-286.
95. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, et al. (2010) Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 29: 55-64.
96. Rizzo AM, Corsetto PA, Montorfano G, Opizzi A, Faliva M, et al. (2012) Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutr J 11: 82.
97. Tajalizadekhoob Y, Sharifi F, Fakhrzadeh H, Mirarefin M, Ghaderpanahi M, et al. (2011) The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study. Eur Arch Psychiatry Clin Neurosci 261: 539-549.
98. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163: 1098-1100. (Pubitemid 44464498)
99. Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, et al. (2008) Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 110: 142-148.
100. Giltay EJ, Geleijnse JM, Kromhout D (2011) Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction. Am J Clin Nutr 94: 1442-1450.
101. DeFina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL (2011) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 93: 455-462.
102. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R (2011) Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25: 1725-1734.
103. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M (2011) Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198: 11-16, sup 11.
104. Iovieno N, Papakostas GI (2012) Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis. J Clin Psychiatry 73: 1300-1306.
105. Souery D, Papakostas GI, Trivedi MH (2006) Treatment-resistant depression. J Clin Psychiatry 67 Suppl 6: 16-22. (Pubitemid 44078108)
106. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67: 1954-1967. (Pubitemid 46048194)
107. Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68: 1056-1061. (Pubitemid 47340326)
108. Ross BM, Seguin J, Sieswerda LE (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 6: 21.
109. Martins JG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28: 525-542.
110. Balanza-Martinez V, Fries GR, Colpo GD, Silveira PP, Portella AK, et al. (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11: 1029-1047.
111. Montgomery P, Richardson AJ (2008) Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev: CD005169.
112. Sarris J, Mischoulon D, Schweitzer I (2012) Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 73: 81-86.
113. Mocking RJ, Assies J, Bot M, Jansen EH, Schene AH, et al. (2012) Biological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial. PLoS One 7: e49431.
114. Caraci F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626: 64-71.
115. Caraci F, Bosco P, Signorelli M, Spada RS, Cosentino FI, et al. (2012) The CC genotype of transforming growth factor-beta1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol 22: 281-289.
116. Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F (2012) New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 73: 504-517.
117. Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, et al. (2012) Dysfunction of TGF-beta1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res 347: 291-301.
118. Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, et al. (2011) TGF-beta1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther 17: 237-249.
119. Markhus MW, Skotheim S, Graff IE, Froyland L, Braarud HC, et al. (2013) Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depression. PLoS One 8: e67617.
120. Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83: 1467S-1476S. (Pubitemid 44713087)
121. Calder PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S.
122. Brooks JD, Milne GL, Yin H, Sanchez SC, Porter NA, et al. (2008) Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 283: 12043-12055.
123. Bhattacharya A, Sun D, Rahman M, Fernandes G (2007) Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J Nutr Biochem 18: 23-30. (Pubitemid 44827716)
124. Zhao Y, Joshi-Barve S, Barve S, Chen LH (2004) Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23: 71-78. (Pubitemid 38200837)
125. Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J (2008) Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects. Nutrition 24: 245-254. (Pubitemid 351179962)
126. Umhau JC, Dauphinais KM, Patel SH, Nahrwold DA, Hibbeln JR, et al. (2006) The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 60: 352-357. (Pubitemid 43354928)
127. Gao F, Kiesewetter D, Chang L, Ma K, Rapoport SI, et al. (2009) Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats. J Lipid Res 50: 2463-2470.
128. Chang CY, Ke DS, Chen JY (2009) Essential fatty acids and human brain. Acta Neurol Taiwan 18: 231-241.